315 related articles for article (PubMed ID: 35657158)
1. Genomic biomarkers to guide precision radiotherapy in prostate cancer.
Sutera P; Deek MP; Van der Eecken K; Wyatt AW; Kishan AU; Molitoris JK; Ferris MJ; Siddiqui MM; Rana Z; Mishra MV; Kwok Y; Davicioni E; Spratt DE; Ost P; Feng FY; Tran PT
Prostate; 2022 Aug; 82 Suppl 1(Suppl 1):S73-S85. PubMed ID: 35657158
[TBL] [Abstract][Full Text] [Related]
2. Genomic Strategies to Personalize Use of Androgen Deprivation Therapy With Radiotherapy.
Glicksman RM; Berlin A
Cancer J; 2020; 26(1):13-20. PubMed ID: 31977380
[TBL] [Abstract][Full Text] [Related]
3. Histology Specific Molecular Biomarkers: Ushering in a New Era of Precision Radiation Oncology.
Sutera P; Skinner H; Witek M; Mishra M; Kwok Y; Davicioni E; Feng F; Song D; Nichols E; Tran PT; Bergom C
Semin Radiat Oncol; 2023 Jul; 33(3):232-242. PubMed ID: 37331778
[TBL] [Abstract][Full Text] [Related]
4. Genomic Markers in Prostate Cancer Decision Making.
Cucchiara V; Cooperberg MR; Dall'Era M; Lin DW; Montorsi F; Schalken JA; Evans CP
Eur Urol; 2018 Apr; 73(4):572-582. PubMed ID: 29129398
[TBL] [Abstract][Full Text] [Related]
5. Unfavorable Pathology, Tissue Biomarkers and Genomic Tests With Clinical Implications in Prostate Cancer Management.
Nguyen JK; Magi-Galluzzi C
Adv Anat Pathol; 2018 Sep; 25(5):293-303. PubMed ID: 29727322
[TBL] [Abstract][Full Text] [Related]
6. Translating a Prognostic DNA Genomic Classifier into the Clinic: Retrospective Validation in 563 Localized Prostate Tumors.
Lalonde E; Alkallas R; Chua MLK; Fraser M; Haider S; Meng A; Zheng J; Yao CQ; Picard V; Orain M; Hovington H; Murgic J; Berlin A; Lacombe L; Bergeron A; Fradet Y; Têtu B; Lindberg J; Egevad L; Grönberg H; Ross-Adams H; Lamb AD; Halim S; Dunning MJ; Neal DE; Pintilie M; van der Kwast T; Bristow RG; Boutros PC
Eur Urol; 2017 Jul; 72(1):22-31. PubMed ID: 27815082
[TBL] [Abstract][Full Text] [Related]
7. Combined value of validated clinical and genomic risk stratification tools for predicting prostate cancer mortality in a high-risk prostatectomy cohort.
Cooperberg MR; Davicioni E; Crisan A; Jenkins RB; Ghadessi M; Karnes RJ
Eur Urol; 2015 Feb; 67(2):326-33. PubMed ID: 24998118
[TBL] [Abstract][Full Text] [Related]
8. Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer.
Casanova-Salas I; Athie A; Boutros PC; Del Re M; Miyamoto DT; Pienta KJ; Posadas EM; Sowalsky AG; Stenzl A; Wyatt AW; Mateo J
Eur Urol; 2021 Jun; 79(6):762-771. PubMed ID: 33422353
[TBL] [Abstract][Full Text] [Related]
9. Prostate Cancer Biomarkers: Current Status.
Hodges KB; Bachert E; Cheng L
Crit Rev Oncog; 2017; 22(5-6):253-269. PubMed ID: 29604917
[TBL] [Abstract][Full Text] [Related]
10. Multifocal Primary Prostate Cancer Exhibits High Degree of Genomic Heterogeneity.
Løvf M; Zhao S; Axcrona U; Johannessen B; Bakken AC; Carm KT; Hoff AM; Myklebost O; Meza-Zepeda LA; Lie AK; Axcrona K; Lothe RA; Skotheim RI
Eur Urol; 2019 Mar; 75(3):498-505. PubMed ID: 30181068
[TBL] [Abstract][Full Text] [Related]
11. Evolution of the genomic landscape of circulating tumor DNA (ctDNA) in metastatic prostate cancer over treatment and time.
Hahn AW; Stenehjem D; Nussenzveig R; Carroll E; Bailey E; Batten J; Maughan BL; Agarwal N
Cancer Treat Res Commun; 2019; 19():100120. PubMed ID: 30743187
[TBL] [Abstract][Full Text] [Related]
12. Determining the Impact of Spatial Heterogeneity on Genomic Prognostic Biomarkers for Localized Prostate Cancer.
Brastianos HC; Murgic J; Salcedo A; Chua MLK; Meng A; Fraser M; Brundage M; Fleshner NE; van der Kwast T; Bristow RG; Boutros PC; Berlin A
Eur Urol Oncol; 2022 Jun; 5(3):362-365. PubMed ID: 32605887
[TBL] [Abstract][Full Text] [Related]
13. An Emerging Landscape for Canonical and Actionable Molecular Alterations in Primary and Metastatic Prostate Cancer.
Dawson NA; Zibelman M; Lindsay T; Feldman RA; Saul M; Gatalica Z; Korn WM; Heath EI
Mol Cancer Ther; 2020 Jun; 19(6):1373-1382. PubMed ID: 32220973
[TBL] [Abstract][Full Text] [Related]
14. Genomic Predictors of Outcome in Prostate Cancer.
Boström PJ; Bjartell AS; Catto JW; Eggener SE; Lilja H; Loeb S; Schalken J; Schlomm T; Cooperberg MR
Eur Urol; 2015 Dec; 68(6):1033-44. PubMed ID: 25913390
[TBL] [Abstract][Full Text] [Related]
15. Intratumoral and Intertumoral Genomic Heterogeneity of Multifocal Localized Prostate Cancer Impacts Molecular Classifications and Genomic Prognosticators.
Wei L; Wang J; Lampert E; Schlanger S; DePriest AD; Hu Q; Gomez EC; Murakam M; Glenn ST; Conroy J; Morrison C; Azabdaftari G; Mohler JL; Liu S; Heemers HV
Eur Urol; 2017 Feb; 71(2):183-192. PubMed ID: 27451135
[TBL] [Abstract][Full Text] [Related]
16. Prostate Cancer Biomarkers: From diagnosis to prognosis and precision-guided therapeutics.
Adamaki M; Zoumpourlis V
Pharmacol Ther; 2021 Dec; 228():107932. PubMed ID: 34174272
[TBL] [Abstract][Full Text] [Related]
17. The role of genetic markers in the management of prostate cancer.
Choudhury AD; Eeles R; Freedland SJ; Isaacs WB; Pomerantz MM; Schalken JA; Tammela TL; Visakorpi T
Eur Urol; 2012 Oct; 62(4):577-87. PubMed ID: 22695242
[TBL] [Abstract][Full Text] [Related]
18. Genomic Correlates to the Newly Proposed Grading Prognostic Groups for Prostate Cancer.
Rubin MA; Girelli G; Demichelis F
Eur Urol; 2016 Apr; 69(4):557-560. PubMed ID: 26563871
[TBL] [Abstract][Full Text] [Related]
19. The Diverse Genomic Landscape of Clinically Low-risk Prostate Cancer.
Cooperberg MR; Erho N; Chan JM; Feng FY; Fishbane N; Zhao SG; Simko JP; Cowan JE; Lehrer J; Alshalalfa M; Kolisnik T; Chelliserry J; Margrave J; Aranes M; Plessis MD; Buerki C; Tenggara I; Davicioni E; Carroll PR
Eur Urol; 2018 Oct; 74(4):444-452. PubMed ID: 29853306
[TBL] [Abstract][Full Text] [Related]
20. The promising role of new molecular biomarkers in prostate cancer: from coding and non-coding genes to artificial intelligence approaches.
Alarcón-Zendejas AP; Scavuzzo A; Jiménez-Ríos MA; Álvarez-Gómez RM; Montiel-Manríquez R; Castro-Hernández C; Jiménez-Dávila MA; Pérez-Montiel D; González-Barrios R; Jiménez-Trejo F; Arriaga-Canon C; Herrera LA
Prostate Cancer Prostatic Dis; 2022 Sep; 25(3):431-443. PubMed ID: 35422101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
